Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 46951-47000 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05124977
Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
NA
Recruiting
590 participants
Started: Sep 20, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05425433
Serial Casting for Upper Extremity Burn Contractures
NA
Recruiting
12 participants
Started: Sep 20, 2022 · Completed: Sep 20, 2025
1 condition
1 sponsor
1 location
NCT06403254
Evaluation of VSS Antibiotic Prophylaxis in Prosthetic Surgery (MRSA)
N/A
Recruiting
700 participants
Started: Sep 20, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT05367609
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
NA
Recruiting
300 participants
Started: Sep 20, 2022 · Completed: Sep 30, 2026
2 conditions
2 sponsors
3 locations
NCT05545930
Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)
NA
Recruiting
20 participants
Started: Sep 20, 2022 · Completed: Jul 1, 2026
1 condition
2 sponsors
1 location
NCT05866874
Monitoring of Vital Signs for Phenotyping of Perioperative Myocardial Infarction/Injury After Noncardiac Surgery
N/A
Recruiting
875 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05336682
Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp
NA
Recruiting
60 participants
Started: Sep 20, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05865158
CardioSafe+: A Platform for Telerehabilitation and Monitoring of Patients With Heart Problems
NA
Recruiting
60 participants
Started: Sep 20, 2022 · Completed: Jun 22, 2024
1 condition
1 sponsor
1 location
NCT05480449
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
PHASE1/PHASE2
Recruiting
89 participants
Started: Sep 20, 2022 · Completed: Sep 20, 2029
2 conditions
2 sponsors
1 location
NCT05403242
RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2
PHASE1/PHASE2
Recruiting
42 participants
Started: Sep 20, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
3 locations
NCT05528848
Multi-System Analysis of Opioid Receptor Binding
PHASE1
Recruiting
60 participants
Started: Sep 20, 2022 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT05504278
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
PHASE1
Recruiting
144 participants
Started: Sep 20, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05461313
Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip
NA
Recruiting
146 participants
Started: Sep 20, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06272799
Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.
N/A
Recruiting
160 participants
Started: Sep 20, 2022 · Completed: Sep 20, 2024
1 condition
1 sponsor
1 location
NCT05564949
A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
NA
Recruiting
15 participants
Started: Sep 20, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
2 locations
NCT06073938
Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement
N/A
Recruiting
30 participants
Started: Sep 20, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05048212
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
PHASE2
Recruiting
20 participants
Started: Sep 20, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05260177
Study on the Effect of 40 Hz Non-Invasive Light Therapy System
NA
Recruiting
62 participants
Started: Sep 20, 2022 · Completed: Dec 1, 2026
1 condition
5 sponsors
1 location
NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE3
Recruiting
810 participants
Started: Sep 20, 2022 · Completed: Nov 30, 2033
1 condition
1 sponsor
266 locations
NCT05202080
Effect of a Pre-operative Internet-based Educational Video on Post Operative Opioid Consumption
NA
Recruiting
220 participants
Started: Sep 20, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05515770
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
PHASE3
Recruiting
1,200 participants
Started: Sep 20, 2022 · Completed: Feb 28, 2026
1 condition
5 sponsors
1 location
NCT05073224
Muscle Function After Childbirth
NA
Recruiting
78 participants
Started: Sep 20, 2022 · Completed: Sep 30, 2024
5 conditions
1 sponsor
2 locations
NCT05437380
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
NA
Recruiting
70 participants
Started: Sep 20, 2022 · Completed: Jun 28, 2026
2 conditions
1 sponsor
1 location
NCT05583942
A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
NA
Recruiting
10 participants
Started: Sep 19, 2022 · Completed: Aug 1, 2025
3 conditions
2 sponsors
2 locations
NCT04758975
Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
PHASE2
Recruiting
55 participants
Started: Sep 19, 2022 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT05363631
Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab
PHASE1/PHASE2
Recruiting
55 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT05574361
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
NA
Recruiting
120 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT05362994
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
NA
Recruiting
54 participants
Started: Sep 19, 2022 · Completed: Feb 28, 2025
3 conditions
2 sponsors
1 location
NCT05391295
Mapping Emotional Dynamics During Corticosteroid Treatment
N/A
Recruiting
12 participants
Started: Sep 19, 2022 · Completed: Mar 31, 2025
2 conditions
1 sponsor
1 location
NCT05285358
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
PHASE1
Recruiting
12 participants
Started: Sep 19, 2022 · Completed: Oct 11, 2028
8 conditions
2 sponsors
1 location
NCT05172245
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
PHASE1
Recruiting
46 participants
Started: Sep 19, 2022 · Completed: Jun 1, 2026
26 conditions
1 sponsor
18 locations
NCT05530694
Rheumatoid Arthritis Shared Decision Making
NA
Recruiting
792 participants
Started: Sep 19, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
4 locations
NCT05492448
Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease
NA
Recruiting
120 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05358535
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
PHASE3
Recruiting
200 participants
Started: Sep 19, 2022 · Completed: Mar 31, 2026
6 conditions
1 sponsor
1 location
NCT05521048
Doxycycline in Cutaneous Schwannoma (NF2)
PHASE1/PHASE2
Recruiting
19 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06222801
The 1st Tumor CytokinoTherapy Database (TCTD-1)
N/A
Recruiting
5,000 participants
Started: Sep 19, 2022 · Completed: Dec 1, 2032
1 condition
1 sponsor
1 location
NCT05456503
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620
PHASE3
Recruiting
72 participants
Started: Sep 19, 2022 · Completed: Aug 31, 2028
3 conditions
2 sponsors
1 location
NCT04887337
Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode
NA
Recruiting
30 participants
Started: Sep 19, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT05680597
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
NA
Recruiting
80 participants
Started: Sep 19, 2022 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT05559164
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
PHASE2
Recruiting
60 participants
Started: Sep 19, 2022 · Completed: Mar 1, 2027
2 conditions
1 sponsor
10 locations
NCT05538416
"Short-term Clinical Outcome of Cortical Bone Trajectory Compared With the Traditional Open and Minimal Invasive Posterior Lumbar Interbody Fusion"
N/A
Recruiting
180 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05553652
The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
NA
Recruiting
720 participants
Started: Sep 19, 2022 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT06171204
The Use of Stromal Vascular Fraction for Knee Arthrosis
NA
Recruiting
10 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06093633
A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
N/A
Recruiting
600 participants
Started: Sep 19, 2022 · Completed: Oct 1, 2025
1 condition
1 sponsor
3 locations
NCT05582928
Effects of EEG- Microstate Neurofeedback on Attention and Impulsivity in Adult Attention-deficit/Hyperactivity Disorder (ADHD) and Neurotypical Controls
NA
Recruiting
60 participants
Started: Sep 19, 2022 · Completed: Jun 30, 2025
2 conditions
3 sponsors
1 location
NCT05377047
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NA
Recruiting
345 participants
Started: Sep 19, 2022 · Completed: Dec 31, 2027
2 conditions
17 sponsors
1 location
NCT05450653
Trial of FETO for Severe Congenital Diaphragmatic Hernia
NA
Recruiting
10 participants
Started: Sep 18, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT05549635
Database and Biobank of Patients With Hypersensitivity Pneumonitis
N/A
Recruiting
50 participants
Started: Sep 18, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05517291
DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease
NA
Recruiting
200 participants
Started: Sep 18, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05741775
Physiotherapy Intervention for Migraine Symptoms
PHASE3
Recruiting
87 participants
Started: Sep 18, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
937
938
939
940
941
942
943
More pages
1333
Next